M 31
Pill imprint M 31 has been identified as Allopurinol 100 mg.
Allopurinol is used in the treatment of gout; hyperuricemia secondary to chemotherapy; calcium oxalate calculi with hyperuricosuria; urinary tract stones; high risk percutaneous transluminal angioplasty (and more), and belongs to the drug classes antigout agents, antihyperuricemic agents. Risk cannot be ruled out during pregnancy.
Allopurinol 100 mg is not subject to the Controlled Substances Act.
See also related documents.
Allopurinol Images
- Imprint:
-
M 31
- Strength:
- 100 mg
- Color:
- White
- Size:
- 10.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- silicon dioxide colloidal
magnesium stearate
microcrystalline cellulose
pregelatinized starch
sodium lauryl sulfate
sodium starch glycolate
- Drug Class:
- Antigout agents
Antihyperuricemic agents - Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-0137
| NDC Code | Manufacturer / Repackager |
|---|---|
| 51079-0205 | UDL Laboratories Inc |
| 68115-0411 | Dispensexpress Inc (repackager) |
Note: Inactive ingredients may vary.
More Allopurinol resources
- Allopurinol
- Allopurinol (Wolters Kluwer)
- allopurinol (Cerner Multum)
- allopurinol Intravenous (Micromedex) - Includes Dosage Information
- Allopurinol (AHFS DI)
- Allopurinol (FDA)
- Allopurinol Injection (FDA)
- Allopurinol (Wolters Kluwer)


